6.39 The inclusion of this criterion would allow the court to refuse to grant leave in these circumstances because the applicant for leave would not be able to show that to do so would be in the best interests of the company.
42 Mr Dodd advanced three reasons for saying that it was not in the best interests of HME that Mr Honeysett be granted the leave which he seeks, namely:-
· Mr Honeysett is the least suitable person to be entrusted with an action on behalf of HME, because of his personal interest in so much of the cross-claim as is brought on his own behalf, as distinct from on behalf of HME;
· Mr Honeysett is not a suitable person to be granted such leave, because he is not capable of making rational decisions; and
· The best interests of HME were that Mr Honeysett and Mr Maher be left to contest and resolve the issues between them, whereupon HME could then consider its position.
43 Mr Sirtes submits that the first two of these reasons are irrelevant considerations for the purposes of s.237(2), because they are not referred to in the five criteria. Mr Dodd responds that personal characteristics and qualities of the applicant are made relevant by the terms of s.237(2)(c), which is expressed as requiring the Court to be satisfied, not that it is in the best interests of HME that leave be granted, but that it is in the best interests of HME that the applicant be granted leave.
44 The force of this response is, however, much weakened by the form of s.237(3), which creates a rebuttable presumption that granting leave is not in the best interests of the company in certain events. The matters there referred to do not suggest that personal qualities of the applicant are relevant. The phrase "best interests" directs attention to the company's separate and independent welfare. Charlton v Baber (2003) 47 ACSR 31, [52]; Fiduciary Limited v Morningstar Research Pty Limited [2005] NSWSC 442, [46]. This imports the familiar concept of the interests of the company as a whole. As to which, see, for example, Peters' American Delicacy Co Limited v Heath (1939) 61 CLR 457; Russell Kinsella Pty Limited (in liq) v Kinsella [1983] 2 NSWLR 452 (Powell J); Richard Brady Franks Limited v Price (1937) 58 CLR 112; Charlton v Baber (2004) 47 ACSR 31, 44 [50]. Whether the "best interests" of the company as a whole reflect those of the shareholders taken together in light of the corporate objects, or those of the creditors which will prevail in the context of insolvency, will be influenced by the status of the company. Walker v Wimborne (1976) 137 CLR 1; 3 ACLR 529; Spies v The Queen (2000) 201 CLR 603; 173 ALR 529; 35 ACSR 500; Charlton v Baber (2004) 47 ACSR 31, (53].
45 Moreover, the existence in an applicant of a personal interest in the outcome of a proposed derivative action, or even of a personal animus against the company, or other members of it, cannot be significant, let alone decisive; they are usual concomitants of the types of disputes which lead to derivative actions, and few if any such actions would be brought but for personal interest on the part of the relevant applicant and in the absence of animus against the company or other shareholders. Corporations Act, Pt 2F.1A was intended to facilitate the bringing of derivative actions where appropriate, and not to impose restrictions which did not previously exist. According to the Explanatory Memorandum, the criteria are aimed at "preventing potentially vexatious or unmeritorious actions that would be detrimental to the company on whose behalf the action was taken" and "seek to strike a balance between the need to provide a real avenue for applicants to seek redress on behalf of the company where it fails to do so and the need to prevent actions proceeding which have little likelihood of success". Explanatory Memorandum, paragraphs 6.1, 6.2. That balance would not be served by excluding applicants who have a genuine grievance in respect of which the company is the proper plaintiff, just because they have a personal interest or animus in doing so.
46 Nor do I think that the mental fitness of an applicant is a relevant consideration. If it were established that an applicant satisfied the five criteria but was incapable of managing his or her affairs, the proper conclusion would be to grant leave, but require that a tutor conduct the proceedings.
47 Accordingly, in my opinion the personal qualities or fitness of the applicant are not a relevant consideration under s.237(2)(c). Its terms are to be construed, in the light of its objects and context (including s.237(3)), as requiring only that the Court be satisfied that the granting of leave is in the best interests of the company.
48 In any event, I would not accept that Mr Honeysett is not now able to act rationally. True it is that a psychologist has expressed the view that in December 2003 he was in no fit state to have made rational decisions, and in fact had made some irrational decisions. Affidavit of Lyn Bartlett sworn 15 June 2005, annexure B, p2.6-7. But his general practitioner has reported that on 10 March 2004 he appeared much better and was back at work for himself and seemed more positive, though he was still on Zoloft; he has not seen him since. Affidavit of Michael Berger sworn 15 June 2005, [19]. A psychiatrist has opined that he had been significantly depressed for several months and [as at 24 April 2005] "is still moderately depressed". Affidavit of Rosalie Wilcox sworn 16 June 2005, annexure B, p6.7-8. This is the most up-to-date evidence of his mental state, and does not warrant any conclusion that the moderate depression from which he apparently suffered in April 2005 is incompatible with the ability to make rational decisions.
49 The submission that the best interests of HME were that any determination whether or not HME should bring the proposed proceedings should abide the outcome of the dispute between the shareholders might derive some support from the judgment of Mullins J in Talisman Technologies Inc v Queensland Electronic Switching Pty Limited. [2001] QSC 324. In that case, application was made for the joinder, as an additional defendant, of a "joint venture company", which was opposed on the ground that the joint venture was at an end, effectively because of the breakdown in the relationship between the warring shareholders. The substantive proceedings sought specific performance of obligations under a shareholders' agreement, to which proceedings the joint venture company was not a necessary party. In refusing leave, Mullins J said that the proposed joinder of the joint venture company as a defendant and its slight involvement in the primary objective of the plaintiffs highlighted the lack of utility of the proceedings for it; and that it added very little to the proceedings to have the joint venture company joined as a party, the reality being that if the substantive proceedings resulted in specific performance of the shareholders' agreement, consequences would follow for the joint venture company which did not have to be previously ventilated in the proceedings. Thus Mullins J concluded that it was not in the best interests of the company that leave be granted.
50 The judgment of Mullins J may properly be understood as based on the view that all the proposed derivative action would achieve would be to enable the company to claim from the defendants 100% of what the existing plaintiffs (who were entitled to half of the shareholding) were already claiming 50%, and that its joinder was therefore unnecessary and added nothing in substance to the proceedings: the applicants could achieve the desired result in proceedings in their own name. So understood, the circumstances of the present case are quite different: here, only HME has standing to bring the claims founded on breach of fiduciary duty, and Mr Honeysett cannot personally claim 50% of what HME could claim on that basis.
51 Moreover, the factual substratum of HME's proposed claim is substantially the same as that which underlies the dispute between Mr Maher and Mr Honeysett personally. See [10] above. That factual substratum is to be litigated in any event. That circumstance makes it highly desirable in the interests of a company whose only shareholders and directors will be litigating the issue in any event, that the subject matter be litigated on behalf of HME concurrently. Santow J adverted to the relevance of a common substratum of fact to the grant of leave under s.237 in Keyrate Pty Limited v Hamarc Pty Limited. [2001] NSWSC 491, [24], [26].
52 Prima facie, the prosecution of an action by or on behalf of a company against an officer for recovery of compensation for damage done to the company by that officer's breach of duty is in the interests of the company. In the context of the present case, the proposed derivative action if successful will enhance the assets of HME available for distribution between the shareholders. As HME has ceased to carry on business, the proposed derivative action will not have a detrimental impact on its business. The only caveat is that the proposed action, particularly if unsuccessful, might expose HME to adverse costs consequences. In this respect, Mr Sirtes drew attention to the observations of Austin J in Morningstar, to the effect that one considerable factor to be weighed against its being in the best interests of a company that leave be granted under s.237 is that, if the derivative action were ultimately to fail, the result would be a substantial costs liability for the company. Austin J referred to the need to strike a balance between the prejudice that the company would suffer if claims were pressed unsuccessfully on its behalf and it was called upon to meet an adverse costs order, and the advantage that it would gain indirectly for the benefit of its shareholders if the claims were successful. McLean v Lake Como Venture Pty Limited [2003] QSC 562 [7]; Fiduciary Limited v Morning Star Research Pty Limited [2005] NSWSC 442, [51]. As Austin J said, where the assertion of claims on behalf of a company is simply a manifestation of aspects of the overall dispute between the parties, it will often be appropriate for the court to address the question of costs in the event that the claims fail, and that a suitable way of doing so is to grant leave on terms that the applicant is responsible for the costs ordered against the company and undertakes not to seek contribution or indemnity from the company.
53 This is at least to some extent a similar case, in that the claims which Mr Honeysett asserts the company has against Mr Maher and Demaher are aspects of the overall dispute between Mr Honeysett and Mr Maher. I conclude that the prosecution of the proposed claim on behalf of HME, which has been conceded and found to be seriously arguable, against a director for recovery of compensation for damage allegedly done to HME by that director's breach of duty, and which if successful will enhance the assets of HME available for distribution between the shareholders, is in the best interests of the company, so long as HME is not exposed to the risk of suffering adverse costs consequences. Mr Sirtes did not oppose the imposition of such a term as was imposed in Morningstar on any grant of leave.
54 Accordingly, I am satisfied:-
· That the personal interest or animus of the applicant and his mental health are not relevant considerations for the purposes of s.237(2)(c);
· That the relief to be claimed by HME in the proposed claim is not such as can be claimed indirectly by Mr Honeysett in a personal claim;
· That the common substratum of fact underlying the proposed derivative action, the defence of Mr Honeysett to Mr Maher's personal claim, and Mr Honeysett's personal cross-claim makes concurrent determination of the proposed cross-claim preferable to deferring HME's claim until after the resolution of the shareholder's dispute, all the more so when there is no interest in HME other than that of Mr Maher and Mr Honeysett;
· That subject to HME being protected from exposure to any adverse costs consequences, prosecution of a claim on behalf of HME against Mr Maher and Demaher to recover compensation for loss suffered or profits made as a result of breach of fiduciary obligation by Mr Maher is in the interests of HME;
· Therefore, that it is in the best interests of HME that Mr Honeysett be granted the leave which he seeks to bring the proposed cross-claim in the name and on behalf of HME, upon terms as to the protection of HME as to costs.
55 However, different considerations inform whether leave is to be granted to defend on behalf of HME the proceedings brought against it, than those which bear on granting leave to bring the proposed cross claim, in particular whether it is in the best interests of HME that the applicant be granted leave to defend on behalf of HME. The proceedings to which HME is a defendant are claims for winding up - essentially although not exclusively on the just and equitable ground - and specific performance of an agreement to which it is alleged (by Mr Maher) that HME as well as Mr Maher and Mr Honeysett are parties. Proceedings between the opposed interests in a deadlocked company have ordinarily been conducted with the company joined as a defendant but unrepresented. There is no need for HME to be represented, because one or other of the parties will advance the arguments which, were it represented, it might. Here, Mr Honeysett, who is already a defendant, can adduce any evidence and advance any argument in his own right which he might have advanced on behalf of HME in answer to the claims made against it. While it might be said that it ordinarily is in the interests of a company to resist its winding up, or to resist an order for specific performance of obligations which it might have under the alleged agreements, that does not necessarily follow in the context of a deadlocked two-member company. In circumstances where the claims against HME can be resisted by Mr Honeysett in his own right as a defendant, it would add nothing to grant him leave to do so on behalf of HME, and I am not satisfied that it is in the best interests of HME that Mr Honeysett be granted leave to intervene in the proceedings for the purpose of taking responsibility on behalf of HME for the defence of the proceedings. Different considerations would arise were Mr Honeysett not himself already a defendant.